Prevention of TACO what Haemovigilance data tell us

Size: px
Start display at page:

Download "Prevention of TACO what Haemovigilance data tell us"

Transcription

1 Prevention of TACO what Haemovigilance data tell us Swisstransfusion, Genève 6. Septembre 03 Markus Jutzi, Morven Rüesch Clinical Reviewer Haemovigilance, Swissmedic Swissmedic Schweizerisches Heilmittelinstitut Hallerstrasse 7 CH-3000 Bern

2 Current Haemovigilance data Transfusion reactions 0 by classification and frequency,% 3.9%,3% 0,5%,0% 0,% 0,% 0,5% 0,% 8,% 7,7% 43,5% FNHTR Allo-immunisation Allergic TR TACO Hypotensive TR Other Haemolytic TR Infection TAD Hyperkalaemia TRALI PTP 59 % High imputability TR s

3 Imputability and severity High imputability: ~ 60 % of all reported transfusion reactions (TR s) ~ 60 % of reported TACO Severity grade 3 or 4 (life threatening or fatal).7 % of all reported TR s 5 % of reported TACO 3

4 Number of cases Life threatening and fatal cases Grade 3&4 TRs Fatal TR's Other Hyperkalaemia Delayed HTR TAD Hypotensive TR Bacterial infection TRALI Acute HTR 3 TRALI Bacterial infection Acute haemolytic TR TACO TACO Allergic TR 0 Year 4

5 Comparison of cumulative incidence (reported TACO cases per blood components transfused) Blood component All components Red cell concentrates Québec * Switzerland Ireland ** France ** : 3 93 : :0 000 : 3 0 : 940 : :8 000 : 450 * Robillard, P. et al; Transfusion associated circulatory overload: The new leading cause of transfusion associated fatalities reported to the Québec Haemovigilance system. Presentation IHS 00 in Dubrovnik ** ANSM; Mise au point sur les oedèmes aigus pulmonaires de sucharge posttransfusionnels. Juillet 0 5

6 Definition(s) of TACO ISBT WP on Haemovigilance, July 0: Occurrence of any 4 of the following: Acute respiratory distress Tachycardia Increased blood pressure Acute or worsening pulmonary oedema on frontal chest X-ray Evidence of positive fluid balance within 6 hours of transfusion. An elevated BNP is supportive of TACO Transfusion reactions (Popovsky et al, AABB Press, 3rd edition) Occurrence of any or all of the following: Dyspnoea Orthopnoea Cyanosis Tachycardia Increased blood pressure Pulmonary / pedal oedema within several hours of transfusion Nonspecific manifestations Headache Tightness in the chest Dry cough 6

7 Number of cases Reports of TACO High imputability cases by severity Grade 4 Grade 3 Grade Grade Year 7

8 Number of cases Reports of TACO All reported cases possible 30 0 Grade 4 Grade 3 Grade Grade Year 8

9 Number of cases Reports of TACO All reported cases Possible TACO: Only mild cases, except severe in possible Grade 4 Grade 3 Grade Grade Year 9

10 TACO reports 0 & TACO, imputability possible, probable or certain 35 high Imputability 4 possible Patient demographics Product type Severity Risk factors Signs and symptoms Preventability (transfusion rate?) 0

11 number of cases by gender TACO reports 0 & 03 Patient demographics of reported cases F M Age group

12 Number of cases Severity 0 & 03 Severity by blood component Grade Grade Grade 3 Grade RBC only RBC + PC PC only Product type

13 Number of cases Severity 0 & 03 Severity by blood component Possibles: RBC RBC + PC RBC + FFP PC Grade Grade Grade 3 Grade RBC only RBC + PC PC only Product type 3

14 Number of cases Risk factors Severity of TACO by risk factors Grade Grade Grade 3 Grade 4 0 no known risk factors heart disease only > 60y only > 60y + heart disease Risk factor > 60y + heart disease + renal failure 4

15 Number of cases Risk factors 0 8 > 60y as only risk: ~ 0 % life threatening events Severity of TACO by risk factors 6 4 Grade Grade Grade 3 Grade 4 0 no known risk factors heart disease only > 60y only > 60y + heart disease Risk factor > 60y + heart disease + renal failure 5

16 Number of cases Risk factors 0 8 > 60y as only risk: ~ 0 % life threatening events Severity of TACO by risk factors Additional risk factors: % life threatening/fatal events 6 4 Grade Grade Grade 3 Grade 4 0 no known risk factors heart disease only > 60y only > 60y + heart disease Risk factor > 60y + heart disease + renal failure 6

17 Signs and symptoms Reported TACO symptoms Signs and symptoms associated with TACO sweating other agitation loss of consciousness abdominal pain nausea/vomiting hypotension pulmonary oedema chest pain tachycardia hypertension hypoxemia dyspnoea chills fever Number of cases 7

18 Percent of cases Reported TACO symptoms Frequency of symptoms 80% 70% 60% 50% 40% 30% All cases 0% 0% 0% Hypertension Tachycardia Dyspnoea Hypoxia pulmonary oedema observed symptoms chest pain 8

19 Percent of cases Reported TACO symptoms Frequency of symptoms 0% 00% 80% 60% 40% Grade Grade Grade 3 / 4 0% 0% Hypertension Tachycardia Dyspnoea Hypoxia pulmonary oedema observed symptoms chest pain 9

20 percent of cases Reported TACO symptoms combinations of symptoms BP & dyspnoea BP or dyspnoea Dyspnoea & hypoxia Grade Grade Grade 3 / 4 Severity 0

21 Number of cases Grade 3 &4 TACO - Preventability 3 Transfusion rate and risk factors No Risk factor > 60y >60y + heart disease >60y + heart disease + renal failure 0 unknown -.5 ml/min > - >6 ml/min Transfusion rate

22 Grade 3 & 4 TACO - Preventability Absence of risk factors transfusion rate: -4 ml/minute One known risk factor Several risk factors Recommended precautions: limit transfusion rate: ml/kg bw/h assess fluid balance careful monitoring of patient consider therapeutic options evaluate patient for each transfusion

23 Key findings Most reported TACO cases occurred in patients > 60y TACO is mainly associated with RBC transfusion 5 % were life threatening or fatal Age > 60 is the most common single risk factor Several risk factors increased severity 3

24 Main clinical aspects Presentation hypertension and dyspnoea are the most common but non-specific symptoms The combination of dyspnoea and hypoxaemia indicate an increased likelihood for a life-threatening or fatal course of the event measure saturation! Management of TACO Recognise and act on unspecific symptoms In case of dyspnoea check O-saturation Look out for additional symptoms Consider diuretics, nitrates and oxygen 4

25 Assess risk factors Prevention Base decision to transfuse on benefit/risk assessment Take overall fluid balance into account In presence of one or more risk factors: Prescribe low transfusion rate of max. ml/kg bw/h Monitor patient carefully (BP, HR, respiration, SaO) Assess patient anew for each unit to be transfused 5

26 Conclusions TACO is the major remaining preventable risk of transfusion in Switzerland It is mainly observed in elderly patients receiving RBC transfusions Pre-transfusion patient risk assessment is essential Less restrictive definition than proposed by ISBT allows recognition of beginning TACO and probably prevention of a life threatening or fatal course of reaction 6

27 Conclusions Preventive measures focus on individualised prescription (medical staff) Low transfusion rate in patients at risk for TACO close monitoring of patient during transfusion (nursing staff) Diuretics as premedication were found to have no effect on the severity of reaction* * Robillard, P. et al; Transfusion associated circulatory overload: The new leading cause of transfusion associated fatalities reported to the Québec Haemovigilance system. Presentation at IHS 00 in Dubrovnik 7

How we View & Approach TACO

How we View & Approach TACO How we View & Approach TACO Annual Blood Transfusion & Hemovigilance Symposium Ede, Netherlands May 22, 3014 Mark A. Popovsky, M.D. Chief Medical Officer, Haemonetics Corporation Associate Clinical Professor,

More information

TACO CASE STUDIES RTC JUNE Kerry Dowling Blood Transfusion Laboratory Manager Jonathan Ricks Blood Transfusion Nurse Practitioner

TACO CASE STUDIES RTC JUNE Kerry Dowling Blood Transfusion Laboratory Manager Jonathan Ricks Blood Transfusion Nurse Practitioner TACO CASE STUDIES RTC JUNE 2017 Kerry Dowling Blood Transfusion Laboratory Manager Jonathan Ricks Blood Transfusion Nurse Practitioner RISK FACTORS - TACO Age over 70 years although also seen in younger

More information

Have you ever managed patients who have experienced an adverse reaction to transfusion?

Have you ever managed patients who have experienced an adverse reaction to transfusion? Have you ever managed patients who have experienced an adverse reaction to transfusion? A. Yes, often B. Yes, occasionally C. No A. 1 in 30 units? B. 1 in 100? C. 1 in 1000? D. 1 in 10,000? SHOT collects

More information

Boot Camp Transfusion Reactions

Boot Camp Transfusion Reactions Boot Camp Transfusion Reactions Dr. Kristine Roland Regional Medical Lead for Transfusion Medicine, VCH Objectives By the end of this session, you should be able to: Describe in common language the potential

More information

TACO: a call to action

TACO: a call to action TACO: a call to action Johanna (Jo) Wiersum-Osselton TRIP (Transfusion and Transplantation Reactions in Patients) Also: Sanquin donor physician No financial conflicts Photo: University of Virginia website

More information

Haemovigilance Annual report 2012

Haemovigilance Annual report 2012 Haemovigilance Annual report 2012 Autumn 2013 1 Annual Haemovigilance Report 2012 The Annual Report was written by: Dr. Morven Rüesch and Dr. Markus Jutzi Clinical Reviewers Haemovigilance / Swissmedic

More information

Blood is serious business

Blood is serious business Transfusion at RCH BLOOD TRANSFUSION Anthea Greenway Dept of Clinical Haematology >10000 fresh blood products per year Supports craniofacial and cardiac surgery Support bone marrow, liver transplant and

More information

Transfusion Reactions:

Transfusion Reactions: Transfusion Reactions: Melissa R. George, D.O., F.C.A.P. Medical Director, Transfusion Medicine & Apheresis Penn State Milton S. Hershey Medical Center Office: HG069, Phone: 717-531-4627 E-mail: mgeorge5@hmc.psu.edu

More information

Transfusion Associated Acute Lung Injury (TRALI)

Transfusion Associated Acute Lung Injury (TRALI) Transfusion Associated Acute Lung Injury (TRALI) Chris Beritela, MS, MT(ASCP)SBB Area Technical Consultant Immucor, Inc. Objectives Define Transfusion-Related Acute Lung Injury (TRALI) and the role of

More information

Transfusion Associated Acute Lung Injury (TRALI) Chris Beritela, MS, MT(ASCP)SBB Area Technical Consultant Immucor, Inc.

Transfusion Associated Acute Lung Injury (TRALI) Chris Beritela, MS, MT(ASCP)SBB Area Technical Consultant Immucor, Inc. Transfusion Associated Acute Lung Injury (TRALI) Chris Beritela, MS, MT(ASCP)SBB Area Technical Consultant Immucor, Inc. Objectives Define Transfusion-Related Acute Lung Injury (TRALI) and the role of

More information

REPORT OF TRANSFUSION ADVERSE REACTION TO BLOOD CENTERS

REPORT OF TRANSFUSION ADVERSE REACTION TO BLOOD CENTERS REPORT OF TRANSFUSION ADVERSE REACTION TO BLOOD CENTERS INSTRUCTIONS: Send the form to ALL blood centers that provided blood components to this patient. Timely reporting is important, so that, if appropriate,

More information

Haemovigilance: Acute transfusion reactions. Paula Bolton-Maggs Medical Director Serious Hazards of Transfusion

Haemovigilance: Acute transfusion reactions. Paula Bolton-Maggs Medical Director Serious Hazards of Transfusion Haemovigilance: Acute transfusion reactions Paula Bolton-Maggs Medical Director Serious Hazards of Transfusion SHOT Cumulative data: 18 years n=14822 Deaths related to transfusion reported in 2015 Total

More information

Definitions of Current SHOT Categories & What to Report

Definitions of Current SHOT Categories & What to Report Definitions of Current SHOT Categories & What to Report Revised March 2011 1 ADVERSE EVENTS TERM DEFINITION WHAT TO REPORT IBCT - Wrong Blood Transfused (Incorrect Blood Component Transfused) Where a patient

More information

Pulmonary complications in the Elderly. Paula Bolton-Maggs Medical Director

Pulmonary complications in the Elderly. Paula Bolton-Maggs Medical Director Pulmonary complications in the Elderly Paula Bolton-Maggs Medical Director What does SHOT do? Serious Hazards of Transfusion Collect data on serious adverse reactions and events related to transfusion

More information

TACO Est ce que cette complication transfusionnelle peut être prédite et prévenue?

TACO Est ce que cette complication transfusionnelle peut être prédite et prévenue? TACO Est ce que cette complication transfusionnelle peut être prédite et prévenue? Jeannie Callum, BA, MD, FRCPC, CTBS En vertu des règles de divulgation, je suis tenu de vous Nothing dire que je suis

More information

Approach to a patient with suspected blood transfusion reaction. Raju Vaddepally, MD

Approach to a patient with suspected blood transfusion reaction. Raju Vaddepally, MD Approach to a patient with suspected blood transfusion reaction Raju Vaddepally, MD Goals Detection of Acute Transfusion Reactions (ATR) Clinical and Laboratory Evaluation of ATR Management of individual

More information

Dr Rock LEUNG Transfusion Safety Officer Queen Mary Hospital, Hong Kong West Cluster

Dr Rock LEUNG Transfusion Safety Officer Queen Mary Hospital, Hong Kong West Cluster Dr Rock LEUNG Transfusion Safety Officer Queen Mary Hospital, Hong Kong West Cluster HOSPITAL TRANSFUSION SERVICE IN HK Single supplier for the territory: HK Red Cross Blood Transfusion Service Public

More information

Transfusion Reactions

Transfusion Reactions Transfusion Reactions From A to T Provincial Blood Coordinating Program Daphne Osborne MN PANC (C) RN We want you to know Definition Appropriate actions Classification Complete case studies Transfusion

More information

EDUCATIONAL COMMENTARY TRANSFUSION-RELATED ACUTE LUNG INJURY

EDUCATIONAL COMMENTARY TRANSFUSION-RELATED ACUTE LUNG INJURY EDUCATIONAL COMMENTARY TRANSFUSION-RELATED ACUTE LUNG INJURY Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE

More information

Blood/Blood Component Utilization and Administration Annual Compliance Education

Blood/Blood Component Utilization and Administration Annual Compliance Education Blood/Blood Component Utilization and Administration Annual Compliance Education This course contains annual compliance education necessary to meet compliance and regulatory requirements. Instructions:

More information

Management of TRALI. Handouts. Continuing Education 5/20/2015.

Management of TRALI. Handouts. Continuing Education 5/20/2015. Management of TRALI Christine Beritela, MS, MT(ASCP)SBB Area Technical Consultant Immucor, Inc. Massimo Mangiola, Ph.D. Director of Special Services Rhode Island Blood Center Handouts http://www.immucor.com/enus/pages/educational-program-handouts.aspx

More information

Transfusion reactions. Jim Taylor Haematology SpR Sheffield

Transfusion reactions. Jim Taylor Haematology SpR Sheffield Transfusion reactions Jim Taylor Haematology SpR Sheffield Pre questions 1. Platelet transfusions are more prone to bacterial contamination compared to red cells. T/F 2. Common causes of an acute transfusion

More information

INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS TABLE OF RECOMMENDED TESTS. Type of Reaction Presentation Recommended Tests Follow-up Tests

INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS TABLE OF RECOMMENDED TESTS. Type of Reaction Presentation Recommended Tests Follow-up Tests Minor Allergic (Urticarial) Urticaria, pruritis, flushing, rash If skin reaction only and mild hives/ rash

More information

Mary Berg, M.D. Medical Director, Transfusion Services Associate Professor of Pathology University of Colorado Hospital

Mary Berg, M.D. Medical Director, Transfusion Services Associate Professor of Pathology University of Colorado Hospital Transfusion Reactions/Complications Mary Berg, M.D. Medical Director, Transfusion Services Associate Professor of Pathology University of Colorado Hospital Acute Transfusion Reactions Can be seen with

More information

Haemovigilance Annual report 2013 Summer 2014

Haemovigilance Annual report 2013 Summer 2014 Summer 2014 Haemovigilance Annual report 2013 1 Haemovigilance Annual report 2013 The annual report was written by: Dr. Markus Jutzi and Dr. Lorenz Amsler Clinical Reviewers Haemovigilance / Swissmedic

More information

Current Concepts Transfusion Morbidity & Mortality St. Charles Health System Grand Rounds, Bend, Oregon. Agenda. Serious Consequences of Transfusion

Current Concepts Transfusion Morbidity & Mortality St. Charles Health System Grand Rounds, Bend, Oregon. Agenda. Serious Consequences of Transfusion Current Concepts Transfusion Morbidity & Mortality St Charles Health System Grand Rounds, Bend, Oregon February 22, 2013 Mark A Popovsky, MD Associate Clinical Professor, Harvard Medical School Vice President

More information

National Haemovigilance Programme

National Haemovigilance Programme National Haemovigilance Programme Annual Report 2013 Written by Dr Krishna Badami, Transfusion Medicine Specialist* Dr Daren Buhrkuhl, Transfusion Medicine Specialist* Dr Deepak Sadani, Transfusion Medicine

More information

Transfusion Related Respiratory Complications:

Transfusion Related Respiratory Complications: Transfusion Related Respiratory Complications: An Update on TRALI, TACO and TAD Marla C. Troughton, MD Medical Director Alabama and Central Gulf Coast Region Disclosure I have no real or apparent conflict

More information

Transfusion Medicine Potpourri. BUMC - Phoenix Internal Medicine Residents September 29, 2015

Transfusion Medicine Potpourri. BUMC - Phoenix Internal Medicine Residents September 29, 2015 Transfusion Medicine Potpourri BUMC - Phoenix Internal Medicine Residents September 29, 2015 Clinical case A 24 year old female with sickle cell anemia has just moved to the area and presents as a new

More information

Revised November 2012

Revised November 2012 Revised November 2012 1 ADVERSE EVENTS IBCT - Wrong Blood Transfused (Incorrect Blood Component Transfused) IBCT- SRNM (Specific Requirements Not Met) Where a patient was transfused with a blood component

More information

Transfusion-Related Acute Lung Injury (TRALI) and Strategies for Prevention. Khalid Abdulla Sharif, MD, MRCP (UK)*

Transfusion-Related Acute Lung Injury (TRALI) and Strategies for Prevention. Khalid Abdulla Sharif, MD, MRCP (UK)* Bahrain Medical Bulletin, Vol. 29, No.4, December 2007 Transfusion-Related Acute Lung Injury (TRALI) and Strategies for Prevention Khalid Abdulla Sharif, MD, MRCP (UK)* Background: Transfusion-Related

More information

Blood Transfusion. Dr William Dooley

Blood Transfusion. Dr William Dooley Blood Transfusion Dr William Dooley Plan Cases Blood groups / Indications Procedure Monitoring / Reactions Cases For following cases: - Would you give them a blood transfusion? - How many units you would

More information

Administration of blood components. Tina Parker - Transfusion Practitioner

Administration of blood components. Tina Parker - Transfusion Practitioner . Administration of blood components Tina Parker - Transfusion Practitioner Red Cells Each unit contains 250-350mls Preserved with glucose and Mannitol to keep the correct tension Lasts 35 days from midnight

More information

Acute Transfusion Reactions (Allergic, Hypotensive and Severe Febrile) (ATR) n=296 11

Acute Transfusion Reactions (Allergic, Hypotensive and Severe Febrile) (ATR) n=296 11 REACTIONS IN PATIENTS: Serious adverse reactions including EU definition ANNUAL SHOT REPORT 2015 Acute Transfusion Reactions (Allergic, Hypotensive and Severe Febrile) (ATR) n=296 11 Authors: Janet Birchall,

More information

Transfusion Reactions. Directed by M-azad March 2012

Transfusion Reactions. Directed by M-azad March 2012 Transfusion Reactions Directed by M-azad March 2012 Transfusion Reactions are Adverse reactions associated with the transfusion of blood and its components Transfusion reactions Non-threatening to fatal

More information

Blood Transfusion Reactions

Blood Transfusion Reactions Blood Transfusion Reactions Introduction Many individuals require blood components and blood products. As per the BC Transfusion Medicine Advisory Group (BCTMAG), a blood component is at therapeutic component

More information

Update on ISBT Interna/onal Survey on Transfusion- transmi9ed Bacterial Infec/ons

Update on ISBT Interna/onal Survey on Transfusion- transmi9ed Bacterial Infec/ons Update on ISBT Interna/onal Survey on Transfusion- transmi9ed Bacterial Infec/ons Edward Chew & Erica Wood On behalf of the WPs on TTID and HV Rationale & construction of survey Demographics of respondents

More information

Frequency and Pattern of Noninfectious Adverse Transfusion Reactions at a Tertiary Care Hospital in Korea

Frequency and Pattern of Noninfectious Adverse Transfusion Reactions at a Tertiary Care Hospital in Korea Original Article Transfusion Medicine Ann Lab Med 2016;36:36-41 http://dx.doi.org/10.3343/alm.2016.36.1.36 ISSN 2234-3806 eissn 2234-3814 Frequency and Pattern of Noninfectious Adverse Transfusion Reactions

More information

Blood Transfusion. Dr Will Dooley

Blood Transfusion. Dr Will Dooley Blood Transfusion Dr Will Dooley Plan Cases OSCE practice scenario Blood groups Monitoring / Reactions Miss Irene Bleede, 23yo Asymptomatic, healthy woman with menorrhagia Hb 78 g/l, MCV 73fl Would you

More information

Blood transfusions in sepsis, the elderly and patients with TBI

Blood transfusions in sepsis, the elderly and patients with TBI Blood transfusions in sepsis, the elderly and patients with TBI Shabbir Alekar MICU, CH Baragwanath Academic Hospital & The University of the Witwatersrand CCSSA Congress 11 June 2015 Packed RBC - complications

More information

Haemovigilance Report 2013

Haemovigilance Report 2013 Haemovigilance Report 213 Haemovigilance Report 213 Privacy Statement This report does not identify or attempt to identify individual patients, clinicians or healthcare institutions, and every reasonable

More information

27/01/2019. Anaemia, Transfusion and TACO Lise Estcourt. Anaemia. What is anaemia?

27/01/2019. Anaemia, Transfusion and TACO Lise Estcourt. Anaemia. What is anaemia? Anaemia, Transfusion and TACO Lise Estcourt 1 Anaemia 2 What is anaemia? 3 1 Anaemia according to WHO 4 Anaemia in palliative care Common (77% men 68% women) Symptoms often non-specific Some causes potentially

More information

MB Guideline 7. Transfusion Reaction- Identification, Management and Reporting

MB Guideline 7. Transfusion Reaction- Identification, Management and Reporting MB Guideline 7 Transfusion Reaction- Identification, Management and Reporting When any unexpected or untoward sign or symptom occurs during or shortly after the transfusion of a blood component, a transfusion

More information

Transfusion-related Acute Lung Injury: Report of Two Cases

Transfusion-related Acute Lung Injury: Report of Two Cases 294) Transfusion-related Acute Lung Injury: Report of Two Cases Čermáková Z. 1,3, Kořístka M. 2, Blahutová Š. 2, Dvořáčková J. 1, Brát R. 1, Valkovský I. 1, Hrdličková R. 2 1 Faculty of Medicine, University

More information

Thinking Twice About Transfusions: When TACOS and TRALIs Turn Treatment Into Tragedy. Megan Boysen Osborn, MD, MHPE

Thinking Twice About Transfusions: When TACOS and TRALIs Turn Treatment Into Tragedy. Megan Boysen Osborn, MD, MHPE Thinking Twice About Transfusions: When TACOS and TRALIs Turn Treatment Into Tragedy Megan Boysen Osborn, MD, MHPE Let s TACO bout Transfusion Reactions Megan Boysen Osborn, MD, MHPE Let s TACO bout Transfusion

More information

TRANSFUSION SAFETY 101 ARE YOU SMARTER THAN A BLOOD BANKER?

TRANSFUSION SAFETY 101 ARE YOU SMARTER THAN A BLOOD BANKER? TRANSFUSION SAFETY 101 ARE YOU SMARTER THAN A BLOOD BANKER? 1. Fatal blood transfusion reactions are most likely the result of: a. Circulatory overload b. ABO incompatible blood due to patient identification

More information

Transfusion Challenges. - Transfusion Reactions - Do they need platelets? Dr. Eoghan Molloy Haem SpR 2016

Transfusion Challenges. - Transfusion Reactions - Do they need platelets? Dr. Eoghan Molloy Haem SpR 2016 Transfusion Challenges - Transfusion Reactions - Do they need platelets? Dr. Eoghan Molloy Haem SpR 2016 Guidance on Transfusion Hospital transfusion guidelines and procedures Irish Blood Transfusion Service

More information

Transfusion-related Acute Lung Injury (TRALI) University of California, San Francisco January 8, 2011

Transfusion-related Acute Lung Injury (TRALI) University of California, San Francisco January 8, 2011 Transfusion-related Acute Lung Injury (TRALI) Mark R. Looney, M.D. Mark R. Looney, M.D. University of California, San Francisco January 8, 2011 TRALI: Case presentation 58 year-old female with degenerative

More information

METHYLENE BLUE-TREATED FRESH FROZEN PLASMA AND RELATED ADVERSE REACTIONS IN FRANCE: THE LONGER THE EXPERIENCE THE MORE ROBUST THE RESULTS

METHYLENE BLUE-TREATED FRESH FROZEN PLASMA AND RELATED ADVERSE REACTIONS IN FRANCE: THE LONGER THE EXPERIENCE THE MORE ROBUST THE RESULTS METHYLENE BLUE-TREATED FRESH FROZEN PLASMA AND RELATED ADVERSE REACTIONS IN FRANCE: THE LONGER THE EXPERIENCE THE MORE ROBUST THE RESULTS Ignacio Alvarez, Macopharma Clinical Scientific Manager, France

More information

Transfusion reactions illustrated

Transfusion reactions illustrated Transfusion reactions illustrated Chapter 1 Transfusion practice 1 Procedure of transfusion practice In general, transfusion-associated incidents occur due to multiple errors, most of which occur in the

More information

MabThera. SC. The wait is over. MabThera delivered in just 5 minutes. SC= subcutaneous injection

MabThera. SC. The wait is over. MabThera delivered in just 5 minutes. SC= subcutaneous injection MabThera SC. The wait is over. MabThera delivered in just 5 minutes Abbreviated Prescribing Information MabThera 1400 mg solution for subcutaneous (SC) injection (Rituximab) Indications: Indicated in adults

More information

COMPLICATIONS OF BLOOD TRANSFUSIONS. :Prepared by Dr. Nawal Mogales & Dr. Mohammed Aqlan

COMPLICATIONS OF BLOOD TRANSFUSIONS. :Prepared by Dr. Nawal Mogales & Dr. Mohammed Aqlan COMPLICATIONS OF BLOOD TRANSFUSIONS :Prepared by Dr. Nawal Mogales & Dr. Mohammed Aqlan COMPLICATIONS OF TRANSFUSIONS Transfusion reaction may result from either : A. Immune transfusion reaction. B. Non

More information

R-Gemcitabine (1000mg/m 2 ) Oxaliplatin Therapy i - 14 day

R-Gemcitabine (1000mg/m 2 ) Oxaliplatin Therapy i - 14 day R-Gemcitabine (1000mg/m 2 ) Oxaliplatin i - 14 day INDICATIONS FOR USE: Regimen Code INDICATION ICD10 Relapsed or refractory CD20 positive diffuse large B cell lymphoma in patients ineligible for stem

More information

2/2/2011. Blood Components and Transfusions. Why Blood Transfusion?

2/2/2011. Blood Components and Transfusions. Why Blood Transfusion? Blood Components and Transfusions Describe blood components Identify nursing responsibilities r/t blood transfusion Discuss factors r/t blood transfusion including blood typing, Rh factor, and cross matching

More information

CrackCast Episode 7 Blood and Blood Components

CrackCast Episode 7 Blood and Blood Components CrackCast Episode 7 Blood and Blood Components Episode Overview: 1) Describe the 3 categories of blood antigens 2) Who is the universal donor and why? 3) Define massive transfusion 4) List 5 physiologic

More information

Chapter 13 ADVERSE TRANSFUSION EVENTS

Chapter 13 ADVERSE TRANSFUSION EVENTS Chapter 13 ADVERSE TRANSFUSION EVENTS PRACTICE POINTS The most common severe reaction is ABO incompatibility caused by mis-identification or mis-labelling of the blood component, patient or pre-transfusion

More information

EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL

EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL Ref. Ares(2015)2319265-03/06/2015 EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL Directorate D - Health systems and products D4 Substances of Human Origin and Tobacco Control Brussels,

More information

Febrile Non-haemolytic Transfusion Reactions. Sue Knowles Epsom and St Helier University Hospitals NHS Trust. Copyright BBTS 2008

Febrile Non-haemolytic Transfusion Reactions. Sue Knowles Epsom and St Helier University Hospitals NHS Trust. Copyright BBTS 2008 Febrile Nonhaemolytic Transfusion Reactions Sue Knowles Epsom and St Helier University Hospitals NHS Trust As many questions as answers Pathophysiology? Frequency following prestorage leucodepletion? How

More information

Blood Management: Improve Transfusion, Decrease Costs!

Blood Management: Improve Transfusion, Decrease Costs! Management: Improve Transfusion, Decrease Costs! Risks of Transfusion Management Issues Strategies to Implement Example of UAB Hospital Margaret Fritsma, MA, MT(ASCP)SBB mgfritsma@charter.net What is Management?

More information

ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) Rv

ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) Rv ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) Rv.8.18.18 ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) SUDDEN PROGRESSIVE FORM OF ACUTE RESPIRATORY FAILURE ALVEOLAR CAPILLARY MEMBRANE BECOMES DAMAGED AND MORE

More information

Oxygen Use in Palliative Care Guideline and Flowchart

Oxygen Use in Palliative Care Guideline and Flowchart Oxygen Use in Palliative Care Guideline and Flowchart Reviewed: October 2013 Gippsland Region Palliative Care Consortium Clinical Practice Group Policy. Title Keywords Ratified Oxygen Use in Palliative

More information

ANAPHYLAXIS Following Vaccination. A Severe Adverse Event. Developed for the Grampians Infection Control Group (GRICG) Version 2.

ANAPHYLAXIS Following Vaccination. A Severe Adverse Event. Developed for the Grampians Infection Control Group (GRICG) Version 2. ANAPHYLAXIS Following Vaccination A Severe Adverse Event Developed for the Grampians Infection Control Group () Version 2.0:2014 Adverse Event Following Immunisation Adverse event following immunisation

More information

TRANSFUSION REACTION AMONG THE BLOOD RECIPIENT - A STUDY OF 120 CASES

TRANSFUSION REACTION AMONG THE BLOOD RECIPIENT - A STUDY OF 120 CASES TRANSFUSION REACTION AMONG THE BLOOD RECIPIENT - A STUDY OF 120 CASES Chowdhury FS 1, Biswas J 2, Siddiqui MAE 3, Hoque MM 4, Adnan SK 5 Abstract: Context: Blood transfusion is a life saving procedure.

More information

Lecture Notes. Chapter 2: Introduction to Respiratory Failure

Lecture Notes. Chapter 2: Introduction to Respiratory Failure Lecture Notes Chapter 2: Introduction to Respiratory Failure Objectives Define respiratory failure, ventilatory failure, and oxygenation failure List the causes of respiratory failure Describe the effects

More information

Haemovigilance by JRCS

Haemovigilance by JRCS Haemovigilance by JRCS 04 Safety Vigilance Division Blood Service Headquarters Table of Contents Haemovigilance system of Japanese Red Cross Society. Reports on adverse reactions and TTIs ) Transfusion-related

More information

RiTUXimab 375 mg/m 2 Therapy-7 day

RiTUXimab 375 mg/m 2 Therapy-7 day RiTUXimab 375 mg/m 2 Therapy-7 day This regimen supercedes NCCP Regimen 00208 rituximab 375mg/m2 therapy-follicular lymphoma as of February 2019 INDICATIONS FOR USE: Regimen *Reimbursement INDICATION ICD10

More information

Transfusion Reactions. Objectives. 1) Identify a transfusion reaction 25/02/16. Dr Matthew Horan. 1) Identify a transfusion reaction

Transfusion Reactions. Objectives. 1) Identify a transfusion reaction 25/02/16. Dr Matthew Horan. 1) Identify a transfusion reaction Transfusion Reactions 25/02/16 Dr Matthew Horan Objectives 1) Identify a transfusion reaction 2) Treat a transfusion reaction 3) Report a transfusion reaction 1) Identify a transfusion reaction Could this

More information

Azathioprine toxicity criteria and severity descriptors for the listing of biological agents for rheumatoid arthritis on the PBS

Azathioprine toxicity criteria and severity descriptors for the listing of biological agents for rheumatoid arthritis on the PBS Azathioprine toxicity criteria and severity descriptors for the listing of biological agents for rheumatoid arthritis on the PBS Only valid for adult patients Azathioprine must be at a dose of at least

More information

25/10/2017. Clinical Relevance of the HLA System in Blood Transfusion. Outline of talk. Major Histocompatibility Complex

25/10/2017. Clinical Relevance of the HLA System in Blood Transfusion. Outline of talk. Major Histocompatibility Complex Clinical Relevance of the HLA System in Blood Transfusion Dr Colin J Brown PhD FRCPath. October 2017 Outline of talk HLA genes, structure and function HLA and immune complications of transfusion TA-GVHD

More information

-Cardiogenic: shock state resulting from impairment or failure of myocardium

-Cardiogenic: shock state resulting from impairment or failure of myocardium Shock chapter Shock -Condition in which tissue perfusion is inadequate to deliver oxygen, nutrients to support vital organs, cellular function -Affects all body systems -Classic signs of early shock: Tachycardia,tachypnea,restlessness,anxiety,

More information

London, 24 January 2000 EMEA/1952/00

London, 24 January 2000 EMEA/1952/00 The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 24 January 2000 EMEA/1952/00 EMEA PUBLIC STATEMENT ON ABACAVIR (Ziagen) IMPORTANT SAFETY INFORMATION

More information

WRHA Blood Conservation Service WRHA Transfusion Practice Committee. TEAM TRANSFUSION Differential Diagnosis of Adverse Events

WRHA Blood Conservation Service WRHA Transfusion Practice Committee. TEAM TRANSFUSION Differential Diagnosis of Adverse Events WRHA Blood Conservation Service WRHA Transfusion Practice Committee TEAM TRANSFUSION Differential Diagnosis of Adverse Events MANITOBA ADVERSE EVENT REPORTING SYSTEM DATA FLOW REACTION Physician orders

More information

A Transfusion Reaction What Do I Do Now? Judith A. Sullivan, MS, MT(ASCP)SBB, CQA(ASQ) ASCLS Region III Triennial Meeting Birmingham AL

A Transfusion Reaction What Do I Do Now? Judith A. Sullivan, MS, MT(ASCP)SBB, CQA(ASQ) ASCLS Region III Triennial Meeting Birmingham AL A Transfusion Reaction What Do I Do Now? Judith A. Sullivan, MS, MT(ASCP)SBB, CQA(ASQ) ASCLS Region III Triennial Meeting Birmingham AL This promotional educational activity is brought to you by Ortho

More information

Transfusion 2004: Current Practice Standards. Kay Elliott, MT (ASCP) SBB SWMC Transfusion Service

Transfusion 2004: Current Practice Standards. Kay Elliott, MT (ASCP) SBB SWMC Transfusion Service Transfusion 2004: Current Practice Standards Kay Elliott, MT (ASCP) SBB SWMC Transfusion Service Massive Transfusion Protocol (MTP) When should it be activated? Massive bleeding i.e. loss of one blood

More information

Summary of the Risk Management Plan (RMP) V. 1.6, July 2017 for BAVENCIO. Avelumab 200 mg/10 ml. Concentrate for Solution for Infusion

Summary of the Risk Management Plan (RMP) V. 1.6, July 2017 for BAVENCIO. Avelumab 200 mg/10 ml. Concentrate for Solution for Infusion Summary of the Risk Management Plan (RMP) V. 1.6, July 2017 for BAVENCIO Avelumab 200 mg/10 ml Concentrate for Solution for Infusion Marketing Authorisation Number 66380 Marketing Authorisation Holder:

More information

2:39 2: Dizziness and nausea Cerebral. 2:57 1: Vomiting Gastro-intestinal

2:39 2: Dizziness and nausea Cerebral. 2:57 1: Vomiting Gastro-intestinal Supplemental: Table B: Detailed description of adverse events by time, treatment group and procedure T-spinal to incident T-spinal to PACU discharge Group THA/TKA Adverse event description Adverse event

More information

Patient Blood Management. Marisa B. Marques, MD UAB Department of Pathology November 17, 2016

Patient Blood Management. Marisa B. Marques, MD UAB Department of Pathology November 17, 2016 Patient Blood Management Marisa B. Marques, MD UAB Department of Pathology November 17, 2016 Learning Objectives Upon completion of the session, the participant will: 1) Differentiate between the various

More information

June For 2010, Swissmedic compiled annual pharmacovigilance statistics in the following sectors:

June For 2010, Swissmedic compiled annual pharmacovigilance statistics in the following sectors: June 2011 In this issue: Local anaesthetics and MetHb 3 Rosiglitazone 4 New: Vaccinovigilance14 DIA EuroMeeting 27 Contacts 33 I: Editorial 1 II: Flash: Signals relating to the safety of medicines from

More information

Paula Bolton-Maggs Medical Director SHOT

Paula Bolton-Maggs Medical Director SHOT Paula Bolton-Maggs Medical Director SHOT Lancet April 30, 1983 The baby was transfused in March 1981 but there was reluctance by reviewers and publishers to publish rapidly NEJM: Confirmed link between

More information

Olive J Sturtevant, MHP, MT(ASCP)SBB/SLS, CQA Director, Cellular Therapy Quality Assurance Dana Farber Cancer Institute

Olive J Sturtevant, MHP, MT(ASCP)SBB/SLS, CQA Director, Cellular Therapy Quality Assurance Dana Farber Cancer Institute Adverse Events associated with Cell Therapy Products Olive J Sturtevant, MHP, MT(ASCP)SBB/SLS, CQA Director, Cellular Therapy Quality Assurance Dana Farber Cancer Institute 2 Objectives Review the types

More information

Figure 1: ATEs related to transfused products per year (N=1,040). 8

Figure 1: ATEs related to transfused products per year (N=1,040). 8 Table of Contents Table of Contents Acknowledgement 4 Executive Summary 5 Methodology 7 Blood Products and ATEs 8 Table 1A: Adverse Transfusion Events (ATEs),N (%) by type of product and year. 8 Figure

More information

BC Cancer Protocol Summary for Treatment of Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia with Fludarabine and rituximab

BC Cancer Protocol Summary for Treatment of Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia with Fludarabine and rituximab BC Cancer Protocol Summary for Treatment of Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia with Fludarabine and rituximab Protocol Code Tumour Group Contact Physicians LYCLLFLUDR Lymphoma Dr.

More information

A transfusion reaction is any adverse effect of transfusion therapy which occurs during or after administration of a blood component

A transfusion reaction is any adverse effect of transfusion therapy which occurs during or after administration of a blood component Brenda C. Barnes, Ph.D., MT(ASCP)SBB 1/2015 1 A transfusion reaction is any adverse effect of transfusion therapy which occurs during or after administration of a blood component Transfusion of any blood

More information

ANAPHYLAXIS. Following Vaccination of Adults. A Severe Adverse Event

ANAPHYLAXIS. Following Vaccination of Adults. A Severe Adverse Event ANAPHYLAXIS Following Vaccination of Adults A Severe Adverse Event Developed for the Grampians Infection Control Group () Version 3.0:2018 Target audience This information package is for nurse immunisers

More information

National Haemovigilance Programme. Annual Report 2012

National Haemovigilance Programme. Annual Report 2012 National Haemovigilance Programme Annual Report 2012 Written by Dr Peter Flanagan, National Medical Director Mr John Dagger, Technical Advisor* Dr Krishna Badami, Transfusion Medicine Specialist* Dr Deepak

More information

Product Information BROWN SNAKE ANTIVENOM AUST R 74897

Product Information BROWN SNAKE ANTIVENOM AUST R 74897 Product Information APPROVED NAME BROWN SNAKE ANTIVENOM AUST R 74897 DESCRIPTION BROWN SNAKE ANTIVENOM is prepared from the plasma of horses immunised with the venom of the brown snake (Pseudonaja textilis).

More information

Alister Jones Patient Blood Management Practitioner NHS Blood and Transplant

Alister Jones Patient Blood Management Practitioner NHS Blood and Transplant Alister Jones Patient Blood Management Practitioner NHS Blood and Transplant All medical RCC transfusions (but only 1 in 3 haematology or oncology cases) in 3 x one week periods Medical specialties include:

More information

Bronchospasm & SOB. Kim Kilmurray Senior Clinical Teaching Fellow

Bronchospasm & SOB. Kim Kilmurray Senior Clinical Teaching Fellow Bronchospasm & SOB Kim Kilmurray Senior Clinical Teaching Fellow LEARNING OBJECTIVES Perform a comprehensive respiratory examination & link clinical signs to underlying pathology Identify the spectrum

More information

Chest diseases Hospital Laboratory Hematology Practice guidelines

Chest diseases Hospital Laboratory Hematology Practice guidelines Chest diseases Hospital Laboratory Hematology Practice guidelines Title RBCs transfusion in Adults SOP Code Policy Owner Hematology Unit Section Hematology Prepared By Dr. Taher Ahmed Abdelhameed Issuing

More information

HAEMOVIGILANCE REPORT 2016

HAEMOVIGILANCE REPORT 2016 HAEMOVIGILANCE REPORT SANBS & WPBTS Haemovigilance Report HAEMOVIGILANCE REPORT PRIVACY STATEMENT This report does not identify or attempt to identify individual patients, clinicians or healthcare institutions,

More information

DERBY-BURTON CANCER NETWORK CONTROLLED DOC NO:

DERBY-BURTON CANCER NETWORK CONTROLLED DOC NO: OBINUTUZUMAB+CHLORAMBUCIL Regimen RDH; Day 1 and 2 Dose to be given on Ward Available for Routine Use in Burton in-patient Derby in-patient Burton day-case Derby day-case Burton community Derby community

More information

TRANSFUSION OF BLOOD COMPONENTS ADMINISTRATION. All blood components are administered according to BOP DHB Policy and NZBS Guidelines.

TRANSFUSION OF BLOOD COMPONENTS ADMINISTRATION. All blood components are administered according to BOP DHB Policy and NZBS Guidelines. STANDARDS All blood components are administered according to BOP DHB Policy and NZBS Guidelines. EQUIPMENT IV administration set with 260 micron filter either integrated blood filter; or add on blood filter

More information

French National Experience. EFS Medical Director

French National Experience. EFS Medical Director HEMOVIGILANCE French National Experience Dr Rachid DJOUDI EFS Medical Director Tehran - December 2015 Hemovigilance in France In France, hemovigilance was defined by law since 1993 (last modified by article

More information

TRANSFUSION TRANSMITTED INJURIES SURVEILLANCE SYSTEM (TTISS): SUMMARY RESULTS. 1 P age

TRANSFUSION TRANSMITTED INJURIES SURVEILLANCE SYSTEM (TTISS): SUMMARY RESULTS. 1 P age TRANSFUSION TRANSMITTED INJURIES SURVEILLANCE SYSTEM (TTISS): 2009-2013 SUMMARY RESULTS 1 P age Acknowledgments: The development of the Transfusion Transmitted Surveillance System (TTISS) would not have

More information

Management of an immediate adverse event following immunisation

Management of an immediate adverse event following immunisation Management of an immediate adverse event following immunisation The vaccinated person should remain under observation for a short interval to ensure that they do not experience an immediate adverse event.

More information

ISBN: Haemovigilance Report 2011

ISBN: Haemovigilance Report 2011 ISBN: 978-0-620-56980-4 Haemovigilance Report 2011 South African Haemovigilance Report 2011 1 Privacy Statement This report does not identify or attempt to identify individual patients, clinicians or

More information

Acute respiratory failure. Arterial blood gas assessment. finn rasmussen 2011

Acute respiratory failure. Arterial blood gas assessment. finn rasmussen 2011 Acute respiratory failure Arterial blood gas assessment finn rasmussen 2011 Normal P a CO 2 = 40mmHg Normal P a O 2 = 90-95 mmhg ALVEOLAR VENTILATION Normal HCO 3- = 22-27 mmol/l H + 2 0 CO + 2 H HCO -

More information

Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off.

Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off. 1 2 EMT OPTIONAL SKILL Naloxone Intranasal Cell Phones and Pagers Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off. 3 4 5 6 Course Outline Introduction

More information

Keeping track of your numbers

Keeping track of your numbers Keeping track of your numbers If you have relapsed or refractory multiple myeloma, keeping track of your numbers can help you take an active role in your care. It s also one way you and your doctor can

More information